Case-based clinical reasoning analysis Not a record of patient care

Musculoskeletal, sports, and rehabilitation

Inflammatory Back Pain in a Young Adult

The decision is whether the pattern warrants rheumatology referral and correctly protocoled sacroiliac imaging despite normal radiographs. HLA-B27 and MRI modify probability but neither a negative allele nor a few nonspecific marrow-edema pixels independently rules disease in or out.

Fully reviewed by Jasaman (Jasmin) Tojjar, MD, PhD

On this page
  1. Case focus
  2. Problem representation
  3. Immediate safety priorities
  4. Prioritized differential diagnosis
  5. Evidence-gathering strategy
  6. Progressive course and interpretation
  7. Management reasoning
  8. Communication and shared decisions
  9. Continuity and safety net
  10. Equity and systems analysis
  11. Reasoning capabilities demonstrated
  12. Key takeaways

A young adult has back pain for eighteen months, prolonged morning stiffness, alternating buttock pain, improvement with movement, and nocturnal waking. Plain radiographs were normal and the symptoms were called mechanical. Axial spondyloarthritis can precede radiographic change, so probability must integrate phenotype, family history, psoriasis, uveitis, inflammatory bowel disease, and objective inflammation.

Case focus#

The decision is whether the pattern warrants rheumatology referral and correctly protocoled sacroiliac imaging despite normal radiographs. HLA-B27 and MRI modify probability but neither a negative allele nor a few nonspecific marrow-edema pixels independently rules disease in or out.

This analysis concentrates on calibration. It compares plausible explanations, asks which observations genuinely discriminate among them, and keeps the working diagnosis open to revision as new evidence arrives.

Problem representation#

The useful representation is not a label alone. It combines the tempo of the problem, the setting, the physiologic or functional threat, the evidence already available, and the important information that is still missing. For this axial spondyloarthritis analysis, the working frame must remain broad enough to compare Axial spondyloarthritis, Mechanical back pain, Sacroiliac stress or postpartum change, Infection or malignancy without allowing a familiar first impression to become an untested conclusion.

The setting materially changes the plan: A rheumatology pathway with structured musculoskeletal examination, pelvic radiography, MRI sacroiliac protocols, and ophthalmology and gastroenterology links.. Available monitoring, access to consultation, travel time, record continuity, and the reliability of follow-through alter what counts as a safe next step. A plan that is reasonable in a continuously monitored environment may be unsafe when results return after discharge or urgent reassessment is difficult.

Immediate safety priorities#

These findings are action signals rather than diagnostic shortcuts. They determine the pace of stabilization, consultation, and escalation while the causal analysis continues in parallel.

Prioritized differential diagnosis#

Axial spondyloarthritis#

What supports it. Young onset, inflammatory pattern, buttock pain, family history, extra-articular disease, or sacroiliitis support it.

What argues against it or keeps uncertainty open. Pure activity-provoked pain and normal high-quality evaluation lower probability.

Discriminating next step. Integrate clinical features, CRP, HLA-B27, and imaging.

Mechanical back pain#

What supports it. Load-related pain, short stiffness, reproducible strain, and improvement with rest support mechanical disease.

What argues against it or keeps uncertainty open. Night pain and prolonged morning stiffness favor inflammation.

Discriminating next step. Assess biomechanics and response while retaining red-flag review.

Sacroiliac stress or postpartum change#

What supports it. Athletics, pregnancy, or mechanical overload can produce MRI edema.

What argues against it or keeps uncertainty open. Typical erosions and coherent inflammatory phenotype strengthen axSpA.

Discriminating next step. Review distribution, structural lesions, and timing with expert radiology.

Infection or malignancy#

What supports it. Fever, weight loss, immune suppression, focal destructive lesion, or severe rest pain supports danger.

What argues against it or keeps uncertainty open. Long stable inflammatory pattern without systemic signs lowers probability.

Discriminating next step. Use urgent labs and imaging when risk features exist.

Fibromyalgia or central pain amplification#

What supports it. Widespread tenderness, fatigue, sleep disruption, and discordant activity measures support amplification.

What argues against it or keeps uncertainty open. Objective synovitis, uveitis, or sacroiliitis confirms coexisting inflammation.

Discriminating next step. Measure both processes so inflammation is neither missed nor overtreated.

The differential is ranked but not closed. Probability, consequence of delay, reversibility, and test burden are considered together. A dangerous alternative can deserve early exclusion even when it is not the statistically most likely explanation.

Evidence-gathering strategy#

Tests are selected because they can change a decision, not because a broad panel feels comprehensive. Results are interpreted with their timing, pretest probability, measurement limitations, recent treatment, and the possibility that an apparently reassuring value was obtained too early or under the wrong conditions.

Progressive course and interpretation#

CRP is normal and HLA-B27 is positive. MRI reviewed by an experienced radiologist shows active sacroiliitis in an anatomically typical distribution. The team confirms the clinical diagnosis, screens extra-articular disease, begins exercise and anti-inflammatory care, and uses objective activity and preferences before considering biologic therapy.

The trajectory is evidence. Improvement after an intervention may support a mechanism without proving it, while nonresponse should prompt a check of the diagnosis, delivery of the intervention, timing, adherence, and competing pathology. Discordant data should be explained rather than averaged away.

Management reasoning#

Management remains proportional to severity and uncertainty. It includes explicit monitoring targets, foreseeable adverse effects, and stop or escalation conditions. Exact drug selection, dosing, and procedure details depend on verified individual factors, current local protocols, contraindications, and the responsible treating team; the analytical value here is the decision structure and its guardrails.

Communication and shared decisions#

Explain that inflammatory back disease is diagnosed from a constellation rather than one gene or scan. Distinguish activity, structural damage, and pain amplification, and discuss treatment as function- and risk-oriented rather than promising a cure.

The communication task includes what is known, what remains uncertain, why the next step is recommended, what alternatives exist, and which change should trigger urgent reassessment. Teach-back, qualified interpretation when needed, accessible formats, and a named owner for pending results turn information into a safer plan.

Continuity and safety net#

Follow-through is verified, not assumed. The record should identify who receives each pending result, the time window for reassessment, the contingency if contact fails, and the clinical or functional outcome that will show whether the plan is working.

Equity and systems analysis#

Women, HLA-B27-negative people, racialized groups, and those without classic radiographic disease are diagnosed later. Apply the same referral threshold, obtain pregnancy-aware imaging, and offer physiotherapy and specialty options accessible to work and caregiving schedules.

Access conditions belong in the causal model. Transportation, medication cost, work schedules, caregiving, health literacy, language, disability access, digital connectivity, and prior experiences of care can alter both the observed presentation and the feasibility of the plan. Addressing those constraints improves diagnostic validity as well as fairness.

Reasoning capabilities demonstrated#

Key takeaways#

Sources and further reading

  1. ASAS-EULAR recommendations for management of axial spondyloarthritis, 2022 update
  2. NICE, Spondyloarthritis in over 16s (NG65)
  3. ACR/SAA/SPARTAN 2019 recommendations for ankylosing spondylitis and nonradiographic axial SpA
  4. ACR Appropriateness Criteria, Inflammatory Back Pain, Known or Suspected Axial Spondyloarthritis

Questions and answers

What is the central decision in this axial spondyloarthritis analysis?

The decision is whether the pattern warrants rheumatology referral and correctly protocoled sacroiliac imaging despite normal radiographs. HLA-B27 and MRI modify probability but neither a negative allele nor a few nonspecific marrow-edema pixels independently rules disease in or out.

Which findings change urgency first?

Acute neurologic compromise matters because Weakness, saddle anesthesia, or bladder dysfunction requires emergency spinal evaluation. Septic pattern also changes the pace because Fever, bacteremia risk, severe focal pain, or immune suppression raises sacroiliac infection concern.

How does this reasoning avoid premature closure?

It compares Axial spondyloarthritis, Mechanical back pain, and Sacroiliac stress or postpartum change; then uses discriminating evidence rather than familiarity alone. For the leading alternative, Integrate clinical features, CRP, HLA-B27, and imaging.

What must happen after the immediate decision?

Seek emergency care for new weakness, bladder or bowel dysfunction, high fever with severe focal pain, or major trauma. Obtain same-day eye assessment for a painful red photophobic eye or sudden visual change. CRP is normal and HLA-B27 is positive. MRI reviewed by an experienced radiologist shows active sacroiliitis in an anatomically typical distribution. The team confirms the clinical diagnosis, screens extra-articular disease, begins exercise and anti-inflammatory care, and uses objective activity and preferences before considering biologic therapy.